Molecular Mechanisms of Neuromodulation in Neuropsychological Disorders
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Nervous System".
Deadline for manuscript submissions: closed (15 June 2023) | Viewed by 287
Special Issue Editors
Interests: neuroinflammation; neuromodulation; pain; depression
Special Issue Information
Dear Colleagues,
Neuropsychological disorders have become a major global health problem, prompting the developing of new, more efficient therapies. To this end, neuromodulation is an excellent method of modulating the activity of various neuronal regions to alleviate the disease. Neuromodulation is a rapidly growing field encompassing a broad spectrum of interventional technologies. These approaches can modify the pathological activity in the nervous system to achieve the best therapeutic results. Neuromodulation refers to intervening and interfacing with the nervous system using electrical, electromagnetic, chemical or optogenetic methods to stimulate, inhibit, modify and/or regulate neural activity. These therapies, including intracranial cortical stimulation (ICS), deep brain stimulation (DBS), transcranial direct current stimulation (tDCS), and transcranial magnetic stimulation (TMS), have all shown promising results across a range of neuropsychological disorders. So far, these therapeutic approaches have been used to treat Tourette's syndrome tics, movement disorders (Parkinson's disease, dystonia and tremors), obsessive–compulsive disorder, impaired consciousness, depression, headaches, chronic pain, sensory disturbances, tinnitus, bladder control, epilepsy, stroke, spasticity and spinal cord injury. Many of the basic molecular mechanisms of neuromodulation are now known. Therefore, this Special Issue will summarize the application of neuromodulation in neuropsychological disorders and discuss the underlying molecular relationships involved.
We look forward to reading your contributions.
Dr. Tahmineh Mokhtari
Prof. Dr. Yunwu Zhang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular mechanisms
- neuropsychological disorders
- neuromodulation
